My understanding is the CHMP (Committee for Medicinal Products for Human Use) oversees all medical device applications as well as numerous other applications that fall under their purview and that Committee is fairly static in terms of its members. I'm not sure where the EMA Review committee fits in but I would have thought that they would only delay a submission based on input from the CHMP. All speculation of course.
Rev
TIS Price at posting:
28.0¢ Sentiment: Buy Disclosure: Held